Abstract
An older, Food and Drug Administration (FDA)-approved antiparasitic compound used for treatment of pinworms (Enterobius vermicularis) may offer a new approach to the search for compounds that block a signaling pathway implicated in colon cancer.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
